Navigation Links
RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
Date:12/5/2012

0&s1=8,242,243.PN.&OS=PN/8,242,243&RS=PN/8,242,243" title="Patent 2" onclick="linkClick(this.href)">“Methods and reagents for detecting CpG methylation with a methyl CpG binding protein (MBP)” covers a highly quantitative and sensitive, bisulfite-free method for measuring DNA methylation at CpG sites and CpG islands using RiboMed’s proprietary Methyl CpG binding fusion protein. This work was supported in part by Small Business Innovative Research grant and contract awards from the National Cancer Institute. In addition to the currently available brain cancer staging test, RiboMed is developing similar DNA methylation profile based diagnostic, prognostic and companion diagnostic tests for ovarian and lung cancers.

Finally, U.S. Patent 8,211,644, entitled “Molecular beacon based methods for detection of targets using Abscription” provides claims to sensitive fluorescence-based methods using molecular beacons to detect the products of Abscription and makes real time detection methods possible. The molecular beacon-based technology makes Abscription more attractive to the vast majority of clinical and research laboratories that do not have access to a mass spectrometer, which is used for the current G-CIMP assay, but routinely use fluorescence detection instruments. The molecular beacon format allows for more streamlined workflows and faster assay set-up. The new fluorescence read-out is readily adapted for the detection of RNA, DNA and protein targets and should have wide applicability in areas such as cancer diagnostics and environmental testing.

About RiboMed Biotechnologies, Inc.
RiboMed Biotechnologies, Inc. (

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioNeutral Group Receives Positive Testing Results From A Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores
2. iBio, Inc. Receives Notice from NYSE MKT Staff that Company Currently is Below Certain Continued Listing Standards
3. AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
4. Ceres Receives $3.5 million from USAID for Trait Stacks
5. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
6. Hertz Fellow, Grant I. Gillary, Receives Hertz Foundation-George Lerman Fellowship
7. Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
8. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
9. Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
10. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
11. Perrigo Receives FDA Approval And Commences Launch Of Morphine Sulfate 100ml/5% Oral Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... February 28, 2015 Increasing its efforts to ... launches its first three episodes of The GMO TRUTH podcast ... this month, as it continues its mission to discover the ... project's first phase, to “uncover the truth about the GMOs ... , The GMO Truth Podcast is an expansion of the ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine” or the “Company”) ... press release disseminated this morning by PR Web, and ... press release states that Immunovaccine has entered into a ... release did not originate from Immunovaccine and there is ... release. Please note that all official statements by ...
(Date:2/27/2015)... Md. and SUMMERLAND, British Columbia ... (NYSE: XON ), a leader in ... agreement to acquire  Okanagan Specialty Fruits (OSF), the ... apple , the world,s first non-browning apple. Through the ... yielding fruit that is more appetizing and convenient for ...
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... its newly developed Bruton,s tyrosine kinase (BTK) inhibitor ... The results of these preclinical evaluations have been ... The feedback received from the Agency is supportive ... Additional preclinical work is required to begin a ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Immunovaccine Disclaims Hoax Press Release 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... in the U.S. and ... in Key Global Markets, ... JERUSALEM and MONTVALE, N.J., July 18 Teva,Pharmaceutical Industries Ltd. ... announced today that they have signed a definitive,agreement under which Teva ...
... Md., July 18 Northwest,Biotherapeutics, Inc. (AIM: NWBS ... NWBT"), today announced that Dr. Alton L. Boynton, ... presentation updating,the Company,s progress in the development of ... "Next Generation Vaccines" conference. The,conference will be held ...
... -- The Defense Advanced Research Projects Agency (DARPA) has ... of Harvard University researchers to study surface enhanced Raman ... three-year effort. , If all phases of the development ... of up to $2.9 million in funding. , Ken ...
Cached Biology Technology:Teva to Acquire Barr 2Teva to Acquire Barr 3Teva to Acquire Barr 4Teva to Acquire Barr 5Teva to Acquire Barr 6Teva to Acquire Barr 7Teva to Acquire Barr 8Northwest Biotherapeutics to Present at Next Generation Vaccine Conference 2DARPA awards research team $1.2M grant to study surface enhanced Raman scattering 2
(Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces the ... as part of its 2015 marketing and branding initiatives ... new consumer website for Wocketwallet.com earlier this month. ... said, "Our new corporate website naturally showcases our premiere ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 28, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present at the upcoming RedChip Global Online CEO Conference ... Gino Pereira , CEO of ... discussing its lead product, the Wocket smart wallet and ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... Bethesda, MD FASEB MARC (Minority Access to Research ... the 2010 Societ Italiana di Patologia (SIP) XXX National ... These awards are meant to promote the entry of ... of the basic science community and to encourage the ...
... PITTSBURGH, Sept. 20 A structural molecule and the cellular ... and could provide new ways of treating the lung infection, ... to scientists at the University of Pittsburgh and the University ... Medicine . Despite decades of research, there has ...
... Inc. (Nasdaq: AWRE ), a global provider ... will introduce and demonstrate several new biometrics software products ... Conference and Technology Expo. The event takes place in ... to be demonstrated include Forensic Workbench, FormScanner, and BioSP™ ...
Cached Biology News:Pitt/Iowa team finds cellular structural molecule can be toxic: Makes pneumonia worse 2Aware to Introduce Several New Software Products at the Biometrics Consortium Conference 2Aware to Introduce Several New Software Products at the Biometrics Consortium Conference 3Aware to Introduce Several New Software Products at the Biometrics Consortium Conference 4
...
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
Rab1A...
... polyclonal to LYZL6 ( Abpromise ... Antigen: Synthetic peptide: DWLCL ... , corresponding to amino acids 46-100 ... Entrez Gene ID: 57151 ...
Biology Products: